Alto Neuroscience, Inc. (ANRO) — Financial Flexibility Index
Alto Neuroscience, Inc. (ANRO) has a Financial Flexibility Index of -0.34x as of December 2025. Free cash flow of $-11.52 Million (operating CF $-11.52 Million minus capex $0.00) represents 0% of total liabilities ($33.55 Million). Also explore ANRO net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alto Neuroscience, Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Alto Neuroscience, Inc. across 5 annual periods. See debt-free asset ratio of Alto Neuroscience, Inc. to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Alto Neuroscience, Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Alto Neuroscience, Inc.. For the full company profile including market capitalisation, see how much is Alto Neuroscience, Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.54x | $-51.74 Million | $-51.77 Million | $33.55 Million | ▲ +11.3% |
| 2024 | -1.74x | $-45.35 Million | $-47.42 Million | $26.08 Million | ▼ -734.6% |
| 2023 | -0.21x | $-32.98 Million | $-33.45 Million | $158.30 Million | ▲ +5.4% |
| 2022 | -0.22x | $-19.66 Million | $-20.39 Million | $89.26 Million | ▼ -5.9% |
| 2021 | -0.21x | $-8.58 Million | $-9.26 Million | $41.27 Million | — |